|
Volumn 11, Issue 6, 1998, Pages 347-357
|
Congenital erythropoietic porphyria
a a a a a |
Author keywords
Acroosteolysis; Congenital erythropoietic porphyria (CEP); Gunther's disease; Porphyria; Uroporphyrinogen III cosynthase
|
Indexed keywords
ADENOSINE PHOSPHATE;
ALPHA TOCOPHEROL;
BETA CAROTENE;
CHLOROQUINE;
GLUCOCORTICOID;
HEMATIN;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
OXYGEN;
PORPHYRIN;
UROPORPHYRIN;
UROPORPHYRINOGEN III SYNTHASE;
ARTICLE;
AUTOSOMAL RECESSIVE INHERITANCE;
BONE MARROW TRANSPLANTATION;
CALCIFICATION;
CLINICAL TRIAL;
CONGENITAL ERYTHROPOIETIC PORPHYRIA;
ERYTHROCYTE;
ERYTHROCYTE TRANSFUSION;
FECES ANALYSIS;
HEMOLYTIC ANEMIA;
HOMOZYGOTE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
OSTEOLYSIS;
PHOTOTOXICITY;
PORPHYRIN METABOLISM;
PRIORITY JOURNAL;
SKIN DEFECT;
SKIN ULCER;
SPLENECTOMY;
SPLENOMEGALY;
STEM CELL TRANSPLANTATION;
SUNLIGHT;
URINARY EXCRETION;
ADOLESCENT;
ADULT;
BONE AND BONES;
FECES;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PORPHYRIA, ERYTHROPOIETIC;
PORPHYRINS;
|
EID: 0032466060
PISSN: 14222868
EISSN: None
Source Type: Journal
DOI: 10.1159/000029857 Document Type: Article |
Times cited : (24)
|
References (20)
|